Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. Bittner VA, Szarek M, Aylward PE, Bhatt DL, et al. J Am Coll Cardiol 2020;75:133-144.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bittner VA, Szarek M, Aylward PE, Bhatt DL, et al. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. J Am Coll Cardiol 2020;75:133-144.
PMID: 31948641